For the Fiscal Year Ended Sept. 30
(Dollars in thousands) |
2002 |
2001 |
|
Assets |
|
|
Current Assets |
73,721 |
83,610 |
Investments |
331,378 |
353,827 |
Assets Whose Use Is Limited |
1,055 |
1,351 |
Property, Plant, and Equipment, net |
218,304 |
213,288 |
Contributions Receivable, less current portion |
20,031 |
15,427 |
Other Assets |
7,853 |
5,958 |
Total Assets |
$652,342 |
$673,461 |
|
Liabilities and Net Assets |
|
|
Current Liabilities |
93,069 |
99,676 |
Long-Term Debt and Other Liabilities |
144,919 |
145,880 |
Net Assets |
|
|
Unrestricted |
198,526 |
221,532 |
Temporarily Restricted |
126,148 |
122,453 |
Permanently Restricted |
89,680 |
83,920 |
Subtotal Net Assets |
414,354 |
427,905 |
Total Liabilities and Net Assets |
$652,342 |
$673,461 |
|
Summary Statistical Information |
|
|
(Unless otherwise noted, includes adult and pediatric patients) |
2002 |
2001 |
Number of Licensed Beds (as of year end) |
27 |
27 |
Adult Inpatient Discharges |
991 |
969 |
Infusion Visits |
53,790 |
48,030 |
Outpatient MD Visits |
84,427 |
79,918 |
Clinical Trials (via Dana-Farber/Harvard Cancer Center) |
519 |
515 |
|
